MBHB Partner Kevin Noonan Quoted in PharmaTech Article Entitled, “Supreme Court Rules in Amgen v. Sandoz”

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a June 12, 2017 edition of PharmaTech.com in an article entitled, “Supreme Court Rules in Amgen v. Sandoz.” On June 12, 2017, the Supreme Court released its opinion in Amgen v. Sandoz. The landmark decision states that biosimilar applicants can notify manufacturers before FDA approves their product. This means biosimilar makers won’t have to wait six-months after their product is approved to bring it to market. View the article